维普中文期刊产品整合服务
15篇 您的检索式:作者名="Dobbin ZC"
    题名 作者 年代 出处 被引量
1Using heterogeneity of the patient-derived xenograft model to identify the chemoresistant population in ovarian eancer显示文摘Dobbin ZC Katre AA Steg AD 2014Oneotarget2014,5,18:1
2The importance of the PI3K/ AKT/MTOR pathway in the progression of ovarian cancer显示文摘Dobbin ZC Landen CN 2013IntJMolSci2013,14,4:1
3Tyrosine- phosphorylated eaveolin-1 (Tyr-14) increases sensitivity to paelitaxel by inhibiting BC12 and BClxl proteins via c-Jun N-terminal kinase 显示文摘Shajahan AN Dobbin ZC Hiekman FE 2012J Biol Chem2012,287,17:1
4The importance of the PI3K/AKT/MTOR pathway in the progression of ovarian cancer显示文摘Dobbin ZC Landen CN 2013Int J Mol Sci2013,14,4:1
5The importance of the P13K/AKT/ MTOR pathway in the progression of ovarian cancer显示文摘Dobbin ZC Landen CN 2013Int J Mol Sei2013,14,4:1
6Ovarian and cer- vical cancer patient derived xenografts:The past,pre sent,and future显示文摘Boone JD Dobbin ZC Straughn JM Jr 2015Gynecol Oneol2015,138,2:1
7The importance of the PI3K/AKT/MTOR pathway in the progression of ovarian cancer显示文摘Dobbin ZC Landen CN 0,,04:1
8Ovarian and cervi- cal cancer patient derived xenografts: the past, present, and future 显示文摘Boone JD Dobbin ZC Michael Straughn J 2015Gynecologic Oncology2015,138,2:1
9The importance of the PI3K/AKT/mTOR pathway in the progression of ovarian cancer 显示文摘Dobbin ZC Landen CN 2013International Journal of Molecular Sciences2013,,:1
10The Importance of the PI3K/AKT/ MTOR Pathway in the Progression of Ovarian Cancer显示文摘Dobbin ZC Landen CN 0,,04:1
11Using heterogeneity of the patient-derived xenograft model to identify the chemoresistant population in ovarian cancer 显示文摘Dobbin ZC Katre AA Steg AD 2014Oncotarget2014,5,18:1
12An ex vivo assay of XRT- induced Rad51 loci formation predicts response to PARP-inbibition in ovarian cancer显示文摘Shah MM Dobbin ZC Nowsheen S 2014Gynecol Oncol2014,134,2:1
13The importance of the PI3K/Akt/mTOR pathway in the progression of ovarian cancer显示文摘Dobbin ZC Landen CN 2013Int J Mol Sci2013,14,4:1
14The importance of the PI3K/AKT/MTOR pathway in the progression of ovarian cancer显示文摘Dobbin ZC Landen CN 2013Int J Mol Sci2013,14,4:1
15The importance of the PI3K/AKT / MTOR pathway in the progression of ovarian cancer显示文摘Dobbin ZC Landen CN 2013Int J Mol Sci2013,14,4:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费